Jonathan Young
Founder at AKERO THERAPEUTICS, INC.
Net worth: 6 M $ as of 29/04/2024
Network origin in Jonathan Young first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 20 | |
National Council on Disability
19
| Government | General Government | 19 |
Apple Tree venture Managemnet Llc//vc
 Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge.
7
| Private Company | Investment Managers | 7 |
| Holding Company | Miscellaneous Commercial Services | 4 | |
Braeburn Pharmaceuticals SPRL
 Braeburn Pharmaceuticals SPRL Medical SpecialtiesHealth Technology Braeburn Pharmaceuticals SPRL develops and commercializes medical products. It’s a pharmaceutical company focused on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain, and schizophrenia. The firm offers Probuohine, CAM2038q1w, CAM2038q4w and Risperdone implant. The company was founded in 2012 and is headquartered in Road Town, British Virgin Islands.
1
| Subsidiary | Medical Specialties | 1 |
FOXKISER LLP
 FOXKISER LLP Miscellaneous Commercial ServicesCommercial Services FOXKISER LLP engages in the provision of strategic advice and counseling services to pharmaceutical and biotechnology companies. Its project works fall into three general categories: advisory services; long-term partnerships; and new company formation. The company was founded by John Daniel Kiser and Allan M. Fox in September 1986 and is headquartered in Washington, DC.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jonathan Young via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| GILEAD SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Marengo Therapeutics, Inc.
 Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| REGENXBIO INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
Limelight Bio, Inc.
 Limelight Bio, Inc. BiotechnologyHealth Technology Limelight Bio, Inc. engages in the development of proprietary technologies, advanced targets, and drug candidates for the expansion of current gene therapy and gene editing approaches. The company was founded by Phil Johnson and Jean Bennett in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Chairman Director/Board Member | |
CleanSlate Centers, Inc.
 CleanSlate Centers, Inc. Medical/Nursing ServicesHealth Services CleanSlate Centers, Inc. operates addiction treatment center. It offers drug treatment, alcohol treatment, and treatment for multiple addictions. The company was founded by Amanda Wilson in 2009 and is headquartered in Northampton, MA. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| RAYZEBIO, INC. | Biotechnology | Founder Founder | |
| BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Director/Board Member General Counsel | |
Tusker Medical, Inc.
 Tusker Medical, Inc. Medical SpecialtiesHealth Technology Tusker Medical, Inc. engages in the development of medical devices for ear, nose, and throat treatments. It offers iontophoresis system and tube delivery system. The company is headquartered in Menlo Park, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
Gala Therapeutics, Inc.
 Gala Therapeutics, Inc. BiotechnologyHealth Technology Gala Therapeutics, Inc. engages in biotech and pharma products. The company was founded in October 2015 by Jonathan Reuben Waldstreicher and is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| INVIVYD, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
Galvanize Therapeutics, Inc.
 Galvanize Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Galvanize Therapeutics, Inc. operates as a biotechnology firm. The company was founded in 2020 and is headquartered in Menlo Park, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Ascidian Therapeutics, Inc.
 Ascidian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascidian Therapeutics, Inc. operates as a biotechnology research and development company. The company is headquartered in Brighton, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Intergalactic Therapeutics, Inc.
 Intergalactic Therapeutics, Inc. BiotechnologyHealth Technology Intergalactic Therapeutics, Inc. is a gene therapy company based in Baltimore, MD. The company is revolutionizing gene therapies with a novel non-viral platform comprised of its versatile synthetic and episomal c3dna molecules. The company uses a customized approach to focal therapeutic delivery using its lead delivery technology, the comet pulsed electric field system, and a proprietary cell-free manufacturing process invented to make gene therapy safer and more accessible for patients. With programs in ophthalmology, oncology, respiratory diseases, and expansion areas including CNS, renal, and musculoskeletal, Intergalactic Therapeutics is dedicated to transforming genetic medicine. The company was founded by Michael D. Ehlers, and Theresa G. H. Heah has been the CEO of the company since 2023. | Biotechnology | Director/Board Member Director/Board Member | |
| Yale University | College/University | Graduate Degree Doctorate Degree | |
Aulos Bioscience, Inc.
 Aulos Bioscience, Inc. BiotechnologyHealth Technology Aulos Bioscience, Inc. operates as a biotechnology firm. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Undergraduate Degree Doctorate Degree | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| VENTYX BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Ceptur Therapeutics, Inc.
 Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Ceptur Therapeutics, Inc. is a company that focuses on developing medicines for severe diseases in the areas of oncology, the central nervous system, nephrology, and immunology. The company is based in Hillsborough, NJ and has subsidiaries in the United States. The company is revolutionizing RNA therapeutics with U1 adaptor technology to address unaddressed diseases. The company was founded by Rafal Goraczniak and P. Peter Ghoroghchian, with P. Peter Ghoroghchian serving as CEO since incorporation. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| LEGEND BIOTECH CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| HEARTWARE INTERNATIONAL INC | Medical Specialties | Director/Board Member Director of Finance/CFO | |
| University of Maryland | College/University | Undergraduate Degree Doctorate Degree | |
| XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Pocket Naloxone Corp.
 Pocket Naloxone Corp. Medical DistributorsDistribution Services Pocket Naloxone Corp. aims to prevent opioid overdose deaths by providing an affordable and accessible OTC naloxone product called Naxswab™ nasal swab. The company is based in Bethesda, MD. The company's vision is to create a world free of opioid overdose deaths, and it has other pipeline assets in development using the same nasal swab applicator delivery platform. The company was founded in 2019 by Behshad Sheldon, Ashanthi Mathai, Kathryn Bowser. Ashanthi Mathai has been the CEO since 2019. | Medical Distributors | Founder Chief Operating Officer | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor | |
| University of California, Berkeley | College/University | Undergraduate Degree Masters Business Admin | |
| KALA BIO, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| DISC MEDICINE, INC. | Biotechnology | Director/Board Member Director/Board Member | |
TARIS BioMedical LLC
 TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Meso Scale Diagnostics LLC
 Meso Scale Diagnostics LLC Medical SpecialtiesHealth Technology Meso Scale Diagnostics LLC develops and markets solutions for multiplex biological assays. Its products include angiogenesis and vascular, bone metabolism, cytokine and chemokine, inflammation, intracellular signaling, neurodegeneration, toxicology, and immuno assay kits. The firms services include assay development, custom conjugation, prototype printing, instrument services and warranties. The company was founded in 1995 and is headquartered in Rockville, MD. | Medical Specialties | Director of Finance/CFO | |
The Foundation Fighting Blindness, Inc.
 The Foundation Fighting Blindness, Inc. Miscellaneous Commercial ServicesCommercial Services The Foundation Fighting Blindness, Inc. provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome. The firm also provides provide information on retinal degenerative diseases to all who request it, in order to increase knowledge and awareness of these diseases. It has locations in Columbia, Denver, Libertyville, New York, Plano, Raleigh and Santa Monica. The company was founded on September 16, 1971 and is headquartered in Columbia, MD. | Miscellaneous Commercial Services | Director/Board Member | |
Tourmaline Bio, Inc.
 Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Tourmaline Bio, Inc., Tourmaline Sub, Inc. is a late-stage clinical biotechnology company based in New York, NY. The company's lead program, Tour006, is an anti-IL-6 antibody with high binding affinity and a naturally long half-life. Tour006 has been studied in over 400 autoimmune patients across six clinical trials. Tourmaline Sub plans to develop Tour006 for thyroid eye disease (TED) and atherosclerotic cardiovascular disease (ASCVD), with additional indications being considered. The company, founded in 2021 by Sandeep Kulkarni and Caley M. Castelein, is focused on developing transformative medicines for patients with life-altering immune diseases. Sandeep Kulkarni has been the CEO since 2021. Tourmaline Sub was acquired by Talaris Therapeutics, Inc. on October 19, 2023, for $43.50 million. | Miscellaneous Commercial Services | Director/Board Member | |
Interuniversitair Micro-Electronica Centrum VZW
 Interuniversitair Micro-Electronica Centrum VZW Miscellaneous Commercial ServicesCommercial Services Interuniversitair Micro-Electronica Centrum VZW, also known as Imec, is a Belgian business accelerator. The non-profit company is based in Leuven, BE and has subsidiaries in the United States, Taiwan, India, Netherlands, and Belgium. Imec.istart is their main program, which helps startups grow and succeed. The Belgian company was founded in 1984 and has been led by CEO Luc van den Hove since then. | Miscellaneous Commercial Services | Director/Board Member | |
| Petrichor Scion Therapeutics Management LLC | Investment Managers | Founder | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
| BRIACELL THERAPEUTICS CORP. | Biotechnology | Founder |
Statistics
International
| United States | 44 |
| Canada | 3 |
| Switzerland | 2 |
| Cayman Islands | 2 |
| Australia | 2 |
Sectoral
| Health Technology | 33 |
| Consumer Services | 8 |
| Commercial Services | 6 |
| Finance | 4 |
| Health Services | 2 |
Operational
| Director/Board Member | 224 |
| Corporate Officer/Principal | 83 |
| Independent Dir/Board Member | 53 |
| Chairman | 40 |
| Undergraduate Degree | 32 |
Most connected contacts
| Insiders | |
|---|---|
| Seth Harrison | 43 |
| Argeris Karabelas | 42 |
| Kevin Bitterman | 36 |
| Mark Iwicki | 26 |
| Jane Henderson | 24 |
| Paul F. Brown | 21 |
| David McIntyre | 21 |
| Aaron Kantoff | 19 |
| Aaron Royston | 19 |
| Tomas Jan Heyman | 18 |
| Preston Brice | 15 |
| Anna Batarina | 14 |
| Graham Walmsley | 13 |
| Behshad Sheldon | 12 |
| Arindam Bose | 12 |
- Stock Market
- Insiders
- Jonathan Young
- Company connections
